ES2444649T3 - Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína - Google Patents

Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína Download PDF

Info

Publication number
ES2444649T3
ES2444649T3 ES10183612.0T ES10183612T ES2444649T3 ES 2444649 T3 ES2444649 T3 ES 2444649T3 ES 10183612 T ES10183612 T ES 10183612T ES 2444649 T3 ES2444649 T3 ES 2444649T3
Authority
ES
Spain
Prior art keywords
protein
cells
gene
cell
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10183612.0T
Other languages
English (en)
Spanish (es)
Inventor
François Mallet
François-Loïc Cosset
Jean-Luc Blond
Dimitri Lavillette
Olivier Bouton
Alessia Ruggieri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9911141A external-priority patent/FR2797888A1/fr
Application filed by Biomerieux SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Biomerieux SA
Application granted granted Critical
Publication of ES2444649T3 publication Critical patent/ES2444649T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES10183612.0T 1999-09-01 2000-09-01 Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína Expired - Lifetime ES2444649T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9911141 1999-09-01
FR9911141A FR2797888A1 (fr) 1999-09-01 1999-09-01 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
FR9911793A FR2797889A1 (fr) 1999-09-01 1999-09-15 Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
FR9911793 1999-09-15

Publications (1)

Publication Number Publication Date
ES2444649T3 true ES2444649T3 (es) 2014-02-26

Family

ID=26235097

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10183612.0T Expired - Lifetime ES2444649T3 (es) 1999-09-01 2000-09-01 Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína
ES00960783T Expired - Lifetime ES2376726T3 (es) 1999-09-01 2000-09-01 Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES00960783T Expired - Lifetime ES2376726T3 (es) 1999-09-01 2000-09-01 Procedimiento de detección de la expresión de una proteína de cubierta de un retrovirus endógeno humano y utilizaciones de un gen que codifica para esta proteína

Country Status (9)

Country Link
US (1) US7442550B1 (enExample)
EP (2) EP2385058B1 (enExample)
JP (2) JP4283475B2 (enExample)
AT (1) ATE531726T1 (enExample)
AU (1) AU7297100A (enExample)
CA (1) CA2383877C (enExample)
ES (2) ES2444649T3 (enExample)
FR (1) FR2797889A1 (enExample)
WO (1) WO2001016171A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004678A2 (en) * 2000-07-07 2002-01-17 Genetics Institute, Llc. Methods and compositions for diagnosing and treating preeclampsia and gestational trophoblast disorders
WO2004087748A1 (en) 2003-04-04 2004-10-14 Centre National De La Recherche Scientifique Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
FR2865403B1 (fr) * 2004-01-23 2009-06-12 Biomerieux Sa Composition pour le traitement d'une pathologie associee a la msrv/herv-w
ES2380228T3 (es) * 2005-03-30 2012-05-09 Viroxis Retrovirus endógeno y proteínas codificadas por env como diana para el tratamiento del cancer
KR101164602B1 (ko) 2008-01-09 2012-07-10 주식회사 케이알바이오텍 배큘로바이러스?기반 백신
EP3235828A1 (en) 2016-04-21 2017-10-25 Genethon Stable pseudotyped lentiviral particles and uses thereof
CN111225682A (zh) 2017-10-20 2020-06-02 吉尼松公司 合胞素用于将药物和基因靶向递送至肺组织的用途
WO2019077149A1 (en) 2017-10-20 2019-04-25 Genethon USE OF SYNCYTINE FOR TARGETING DRUG AND GENE ADMINISTRATION TO REGENERATE MUSCLE TISSUE
JP7344300B2 (ja) 2018-09-18 2023-09-13 ブイエヌブイ ニューコ インク． Ａｒｃベースのカプシドおよびその使用
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663040B1 (fr) 1990-06-11 1995-09-15 Bio Merieux Procede de detection d'une sequence nucleotidique selon la technique d'hybridation sandwich.
US6312921B1 (en) * 1996-07-26 2001-11-06 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2298834C (fr) * 1997-07-07 2015-03-10 Bio Merieux Sequences retroviraux endogenes, associees a des maladies auto-immunes et/ou a des perturbations de la grossesse
WO1999060020A1 (en) * 1998-05-18 1999-11-25 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
EP2385058A1 (fr) 2011-11-09
JP4283475B2 (ja) 2009-06-24
ES2376726T3 (es) 2012-03-16
JP4824731B2 (ja) 2011-11-30
AU7297100A (en) 2001-03-26
EP2385058B1 (fr) 2013-11-06
EP1212359A1 (fr) 2002-06-12
JP2003510032A (ja) 2003-03-18
CA2383877A1 (fr) 2001-03-08
JP2009072194A (ja) 2009-04-09
EP1212359B1 (fr) 2011-11-02
CA2383877C (fr) 2014-04-15
FR2797889A1 (fr) 2001-03-02
US7442550B1 (en) 2008-10-28
WO2001016171A1 (fr) 2001-03-08
ATE531726T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
JP4824731B2 (ja) ヒト内因性レトロウイルスのエンベロープタンパク質の発現を検出する方法、並びに上記タンパク質をコードする遺伝子の使用
Löwer et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation.
JP2013046619A (ja) 癌と関連するガンマレトロウイルス
US5643770A (en) Retroviral vector particles expressing complement inhibitor activity
HERCHENRÖDER et al. Infectious proviral clones of chimpanzee foamy virus (SFVcpz) generated by long PCR reveal close functional relatedness to human foamy virus
US5710037A (en) Retroviral vector particles
Jiang et al. Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma
ES2208942T3 (es) Proteinas e4 de adenovirus para inducir la muerte celular.
EP1651667B1 (en) Protein with fusogenic activity, nucleic acid sequences encoding said protein and pharmaceutical compositions comprising the same
US20040142449A1 (en) Replication-competent molecular clones of porcine endogenous retrovirus class a and class b derived from pig and human cells
EP0520029B1 (en) Methods and compositions for the treatment of malignancies in which a protein kinase is associated
US6277601B1 (en) Expression of a foamy virus envelope protein
JP2002512530A (ja) 自己免疫疾患および／または妊娠障害に関連する内因性レトロウイルス配列
Stewart et al. trans-Acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase
US20130115602A1 (en) Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders
ES2247708T3 (es) Material nucleico retroviral y fragmentos de nucleotidos notablemente asociados a la esclerosis multiple y/o a la poliartritis reumatoide, para obtener un diagnostico, y usos profilactivos y terapeuticos.
US20150197803A1 (en) Method for Detecting or Measuring the Impact of a Viral Vector Composition on Eukaryotic Cells and Biomarkers Used Thereof
US6987003B1 (en) Mammalian stauffen and use thereof
Fulton et al. Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus
Patarca Chronic retroviruses and oncogenesis
US20030104357A1 (en) Jaagsiekte sheep retroviral packaging cell lines and methods relating thereto
ES2324755B1 (es) Polipeptido de la proteina gp120 capaz de inhibir el ciclo vital del virus del sida.
US20040253581A1 (en) Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins
Murcia Late restriction induced by an endogenous retrovirus
Hind III et al. C. C-myc Amplification in HL-60 DNA